Ascendis Pharma A/S
ASND · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $539,092 | $494,046 | $517,923 | $559,543 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $134,734 | $110,452 | $66,685 | $166,280 |
| Inventory | $302,022 | $303,381 | $293,071 | $295,609 |
| Other Curr. Assets | $41,933 | $45,078 | $43,808 | $39,429 |
| Total Curr. Assets | $1,017,781 | $952,957 | $921,487 | $1,060,861 |
| Property Plant & Equip (Net) | $101,764 | $93,542 | $92,447 | $98,714 |
| Goodwill | $0 | $0 | $0 | $3,495 |
| Intangibles | $3,742 | $3,790 | $3,909 | $533 |
| Long-Term Investments | $28,303 | $34,902 | $40,938 | $13,575 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3,160 | $2,711 | $2,657 | $2,317 |
| Total NC Assets | $136,969 | $134,945 | $139,951 | $118,634 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,154,750 | $1,087,902 | $1,061,438 | $1,179,495 |
| Liabilities | – | – | – | – |
| Payables | $78,601 | $93,718 | $84,370 | $96,394 |
| Short-Term Debt | $482,281 | $462,348 | $489,960 | $491,536 |
| Tax Payable | $0 | $0 | $1,573 | $1,222 |
| Deferred Revenue | $4,160 | $1,789 | $1,190 | $936 |
| Other Curr. Liab. | $421,442 | $377,145 | $308,415 | $317,775 |
| Total Curr. Liab. | $986,484 | $935,000 | $885,508 | $907,863 |
| LT Debt | $331,369 | $330,186 | $357,312 | $365,080 |
| Deferred Rev, NC | $692 | $692 | $692 | $5,000 |
| Deferred Tax Liab, NC | $10,280 | $9,596 | $7,733 | $7,258 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $342,341 | $340,474 | $365,737 | $377,338 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,328,825 | $1,275,474 | $1,251,245 | $1,285,201 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,284 | $8,211 | $8,187 | $8,149 |
| Retained Earnings | -$2,705,420 | -$2,666,427 | -$2,657,593 | -$2,559,700 |
| AOCI | -$1,269 | $309 | $1,708 | $1,783 |
| Other Equity | $2,523,746 | $2,470,335 | $2,457,891 | $2,444,062 |
| Total Equity | -$174,075 | -$187,572 | -$189,807 | -$105,706 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,154,750 | $1,087,902 | $1,061,438 | $1,179,495 |
| Net Debt | $274,558 | $298,488 | $329,349 | $297,073 |